Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis
Wei-Qiang Chen(Feinstein Institute for Medical Research), Haichao Wang(Feinstein Institute for Medical Research)
Cited by 2
Related Papers
Development of Procathepsin L (pCTS-L)-Inhibiting Lanosterol-Carrying Liposome Nanoparticles to Treat Lethal Sepsis
|International Journal of Molecular Sciences|2023|10
Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction
|bioRxiv (Cold Spring Harbor Laboratory)|2020|4